open federal funding opportunity

Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)

Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood. The purpose of this initiative is to advance translational re…

Agency

National Institutes of Health

Opportunity number

PAR-25-040